BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38088245)

  • 21. Both Age and Disease Duration are Associated with Clinical Phenotype of Hori's Nevus in Chinese: A Retrospective Analysis of 497 Cases.
    Zhong Y; Huang L; Yan T; Chen Y; Yang B; Man MQ
    Clin Cosmet Investig Dermatol; 2021; 14():65-71. PubMed ID: 33500645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of platelet-rich plasma efficacy in melasma.
    Acar A; Ozturk A; Sokmen N; Unal I; Ertam Sagduyu I
    J Cosmet Laser Ther; 2022 Jul; 24(1-5):36-39. PubMed ID: 35852165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.
    Kung KY; Shek SY; Yeung CK; Chan HH
    Lasers Surg Med; 2019 Jan; 51(1):14-22. PubMed ID: 30357871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A split-face, single-blinded, randomized controlled comparison of alexandrite 755-nm picosecond laser versus alexandrite 755-nm nanosecond laser in the treatment of acquired bilateral nevus of Ota-like macules.
    Yu W; Zhu J; Yu W; Lyu D; Lin X; Zhang Z
    J Am Acad Dermatol; 2018 Sep; 79(3):479-486. PubMed ID: 29288102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective study of 1064-nm Q-switched Nd:YAG laser therapy for acquired bilateral nevus of Ota-like macules.
    Yang X; Bi C; E T; Lin L; Cao Y
    Skin Res Technol; 2023 Mar; 29(3):e13298. PubMed ID: 36973977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset Ito's nevus: an uncommon acquired dermal melanocytosis.
    Mataix J; López N; Haro R; González E; Angulo J; Requena L
    J Cutan Pathol; 2007 Aug; 34(8):640-3. PubMed ID: 17640235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of nevus of Ota by the Q-switched alexandrite laser.
    Alster TS; Williams CM
    Dermatol Surg; 1995 Jul; 21(7):592-6. PubMed ID: 7606368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
    Patil NK; Bubna AK
    Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Laser-Responsive Dermal Pigmentary Conditions in Type III-IV Asian Skin With a 755-nm Picosecond Pulse Duration Laser: A Retrospective Review of Its Efficacy and Safety.
    Koh YP; Tan AWM; Chua SH
    Dermatol Surg; 2020 Nov; 46(11):e82-e87. PubMed ID: 32068548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nevus of Ota in dark skin--an uncommon but treatable entity.
    Fusade T; Lafaye S; Laubach HJ
    Lasers Surg Med; 2011 Dec; 43(10):960-4. PubMed ID: 22127621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of using platelet-rich plasma versus chemical peeling in periorbital hyperpigmentation.
    Ellabban NF; Eyada M; Nada H; Kamel N
    J Cosmet Dermatol; 2019 Dec; 18(6):1680-1685. PubMed ID: 31021041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of characteristics of acquired bilateral nevus of Ota-like macules and nevus of Ota according to therapeutic outcome.
    Lee B; Kim YC; Kang WH; Lee ES
    J Korean Med Sci; 2004 Aug; 19(4):554-9. PubMed ID: 15308847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo reflectance confocal microscopy for evaluating common facial hyperpigmentation.
    Zeng X; Qiu Y; Xiang W
    Skin Res Technol; 2020 Mar; 26(2):215-219. PubMed ID: 31544996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of carboxytherapy and platelet-rich plasma in treatment of periorbital hyperpigmentation: A comparative clinical trial.
    Nofal E; Elkot R; Nofal A; Eldesoky F; Shehata S; Sami M
    J Cosmet Dermatol; 2018 Dec; 17(6):1000-1007. PubMed ID: 29297970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal Platelet-Rich Plasma for the Treatment of Melasma: A Clinical and Dermoscopic Evaluation in Dark Skin.
    Rout A; Mani S; Bala N
    J Cutan Aesthet Surg; 2023; 16(4):300-305. PubMed ID: 38314355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-rich plasma versus carboxytherapy for the treatment of periocular hyperpigmentation; which approach is superior?
    Asilian A; Amiri A; Mokhtari F; Faghihi G; Iraji F; Mozafarpoor S
    Dermatol Ther; 2021 Jul; 34(4):e14980. PubMed ID: 33991032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized control study of the prevention of hyperpigmentation post Q-switched Nd:YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream.
    Uaboonkul T; Nakakes A; Ayuthaya PK
    J Cosmet Laser Ther; 2012 Jun; 14(3):145-9. PubMed ID: 22471899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-Rich Plasma in Melasma-A Systematic Review.
    Sarkar R; Gupta M
    Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nevus of Ota: clinical aspects and management.
    Chan HH; Kono T
    Skinmed; 2003; 2(2):89-96; quiz 97-8. PubMed ID: 14673306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laser eradication of pigmented lesions: a review.
    Polder KD; Landau JM; Vergilis-Kalner IJ; Goldberg LH; Friedman PM; Bruce S
    Dermatol Surg; 2011 May; 37(5):572-95. PubMed ID: 21492309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.